Primary malignancy in patients undergoing immunosuppression for renal transplantation.
D000328:Adult; D002277:Carcinoma / Q000139:chemically induced / Q000453:epidemiology; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced / Q000453:epidemiology; D004407:Dysgerminoma / Q000139:chemically induced / Q000453:epidemiology; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016030:Kidney Transplantation; D007938:Leukemia / Q000139:chemically induced / Q000453:epidemiology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000139:chemically induced / Q000453:epidemiology; D008228:Lymphoma, Non-Hodgkin / Q000139:chemically induced / Q000453:epidemiology; D008297:Male; D009369:Neoplasms / Q000139:chemically induced* / Q000453:epidemiology*; D010954:Plasmacytoma / Q000139:chemically induced / Q000453:epidemiology
D007166:Immunosuppressive Agents